Clinical Trials Browser

Phase 2 × Breast Neoplasms × flibanserin × Clear all

NCT03707340 2025-11-04

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

Phase 2 Active not recruiting

Breast Neoplasms